Sign in
CompletedNo phase

Efficiency And Quality In Post-Surgical Pain Therapy After Discharge

Key facts

Who runs it
University of Nebraska
Where
Omaha, United StatesSee the site
Trial code
Status
Completed
People taking part
711 people enrolled
Started
2 May 2022
Ended
10 Dec 2023
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Empowering Patient to Steer Their Pain Management After Surgery
  • Provider-facing Prescription Aid
Record updated
1 July 2025

Who can take part

Age
19 years to 89 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • 19-89 years old
  • Access to a smartphone (iOS or Android)
  • Inpatient surgery requiring at least over-night hospitalization and anticipated discharge to home

Who cannot take part

  • Long-term opioid therapy (AHRQ definition - opioid use on most days >3 months) prior to surgery
  • Re-hospitalization within 30 days
  • Pregnant
  • Unable to read the English language
  • Discharge to a post-acute care facility
  • Contraindications to opioids, acetaminophen, or NSAIDs

Where in United States

  • University of Nebraska Medical CenterOmaha, United States

About the trial

What the trial wants to find out

Following inpatient surgery, more than 80% of patients are prescribed opioids for use after discharge, yet up to 90% of patients report leftover opioids, and only 16% maximize non-opioid therapy. The proposed study seeks to test a provider-facing decision support tool and a participant-facing smartphone app to reduce the amount of opioids prescribed and taken following discharge, while ensuring effective treatment of pain after surgery. Adult participants with smart phones having had inpatient surgery requiring at least over-night hospitalization with anticipated discharge to home will be randomized to one of the two groups. Study measurements will include self-reported cumulative amounts of opioids taken after discharge, non-opioid analgesic taken, prescribed post-discharge opioid doses in morphine milligram equivalents (MME), pain intensity and pain interference scores (PROMIS), need for additional opioid prescriptions within one-month post-discharge, as well as any self-reported disposal of leftover medications.

The 4 groups in the trial

  • UControlPain App With Only Data Collection Function (Control)No study treatment, for comparison

    UControlPain App with only data collection function. No provider-facing prescription intervention.

  • UControlPain Educational App OnlyExisting treatment, for comparison

    UControlPain app with education components. No provider-facing prescription intervention.

    Treatment: Empowering Patient to Steer Their Pain Management After Surgery

  • UControlPain App and Provider Facing ToolExisting treatment, for comparison

    UControlPain app with education components and provider-facing prescription intervention. Once half of the subjects are enrolled, the provider-facing tool will be turned on. Participants will be masked to when the provider-facing tool is activated.

    Treatment: Empowering Patient to Steer Their Pain Management After Surgery and Provider-facing Prescription Aid

  • Provider Facing Tool OnlyExisting treatment, for comparison

    UControlPain App with only data collection function. Provider-facing prescription intervention. Once half of the subjects are enrolled, the provider-facing tool will be turned on. Participants will be masked to when the provider-facing tool is activated.

    Treatment: Provider-facing Prescription Aid

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
1 July 2025